Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pharmacokinetic and Pharmacodynamic Evaluation of 3 Standard Formulations of Δ9-THC in Healthy Volunteers and Post-chemotherapy Patients in Colombia

NCT05272865 is registered in ClinicalTrials.gov with LaSanta S A S as lead sponsor.

NCT NCT05272865
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05272865 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pharmacokinetic and Pharmacodynamic Evaluation of 3 Standard Formulations of Δ9-THC in Healthy Volunteers and Post-chemotherapy Patients in Colombia
Lead sponsor
LaSanta S A S
Phase
Phase 1/2
Overall status
Unknown status
Start date
August 15, 2023
Completion date
October 17, 2024
Enrollment
334 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer pain, cancer related pain, nausea post chemotherapy, neoplasms, vomiting